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Abstract – The eﬀect of ovotransferrin (ovoTF), human lactoferrin (hLF) and bovine lactofer-
rin (bLF) on the obligate intracellular pathogen Chlamydophila (Cp.) psittaci was evaluated using
a model of Buﬀalo Green Monkey kidney (BGM) cells and HD11 chicken macrophages as ar-
tificial hosts. Firstly, the eﬀect of transferrins on the infectivity of the bacteria was evaluated.
Pre-incubation of Cp. psittaci with 0.5 to 5 mg/mL ovoTF prior to infecting BGM cells significantly
lowered the infection rate (P < 0.05). For both lactoferrins, the infection rate could only be reduced
with 5 mg/mL, albeit not significantly as compared to the infection rate created by the untreated
bacteria. Secondly, transferrins were tested for their ability to influence bacterial adhesion and entry
in HD11 cells. Maximal non-cytotoxic and non-bactericidal concentrations of 0.05 mg/mL ovoTF
and 0.5 mg/mL hLF and bLF were used. Overall, ovoTF was more eﬀective than human and bovine
LF in inhibiting bacterial irreversible attachment and cell entry and the latter was accompanied by
a dose-dependent reduction of actin recruitment at the bacterial entry site. However, once bacte-
ria had entered HD11 cells, transferrins had apparently no eﬀect on intracellular replication. The
present findings suggest a possible role for transferrins and especially ovoTF, in preventing avian
Cp. psittaci infections.
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1. INTRODUCTION
As obligate intracellular Gram-negative
bacteria, Chlamydiaceae share a unique
biphasic developmental cycle. Infectious
elementary bodies (EB) enter the host cell
and transform into metabolic active retic-
* Corresponding author:
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ular bodies (RB). These RB replicate in
an envelope-like structure called an in-
clusion. Approximately 50 h later, newly
formed EB escape from the cell to start a
new infectious cycle. Chlamydophila (Cp.)
psittaci infects birds, causing respiratory
infections by colonization of mucosal epi-
thelial cells and macrophages of the res-
piratory tract, and spreading to various
Article available at http://www.vetres.org or http://dx.doi.org/10.1051/vetres:2007028
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organs. In man, Cp. psittaci causes psitta-
cosis or parrot fever [2].
Lactoferrin (LF) is a member of the
transferrin family of iron-binding glyco-
proteins [21] and is predominantly present
in milk, tears, saliva as well as in vaginal
secretions. This iron-binding protein is in-
volved in host defense mechanisms related
to the non-immune defense system against
pathogenic bacteria, fungi, and protozoa,
both directly and through regulation of the
inflammatory response [38]. Antimicrobial
functions ascribed to this protein or its
peptides include iron sequestration [4],
destabilization of the outer membrane of
Gram-negative bacteria through binding
of bacterial lipopolysaccharides (LPS) [3,
7, 12, 13, 25], selective permeation of
ions [1], modulation of bacterial entry into
host cells through gene regulation [5] and
disrupting the bacterial Type III secre-
tion system [23]. In birds, the extracellu-
lar iron-binding glycoprotein ovotransfer-
rin (ovoTF) or conalbumin belonging to
the transferrin family, is synthesized by
the liver and oviduct and is as a con-
sequence predominantly present in serum
and egg-white [14, 27]. Ovotransferrin is
involved in iron transport and iron deliv-
ery to cells [19,20], but is also proposed to
exert antibacterial activity by permeating
outer membranes, reaching the inner mem-
brane and causing selective permeation of
ions and dissipation of electrical poten-
tial [1]. A 92-amino acid ovotransferrin
peptide, OTAP-92, was also found to be ca-
pable of killing Gram-negative bacteria by
crossing the bacterial outer membrane by
self-promoted uptake, and damaging the
cytoplasmic membrane [17, 18].
Anti-chlamydial activities of lactoferrin
or ovotransferrin in mammalian or avian
hosts have not been investigated. In or-
der to establish whether these transferrins
are capable of inhibiting chlamydial infec-
tions, we tested both human and bovine
lactoferrin, as well as ovotransferrin in
our model of Buﬀalo Green Monkey kid-
ney (BGM) cells and chicken macrophages
(HD11 cells).
2. MATERIALS AND METHODS
2.1. Organism and cell culture
Cp. psittaci genotype D strain
92/1293 [36], a well-characterized
virulent strain, was used in this study. The
eﬀect of transferrins on Cp. psittaci was
examined by use of Buﬀalo Green Mon-
key kidney (BGM) cells and the chicken
macrophage-like cell line HD11 [6]. BGM
cells were cultured in Eagle’s minimal
essential medium (MEM) supplemented
with 10% heat-inactivated fetal bovine
serum (Invitrogen, Merelbeke, Belgium),
2 mM L-glutamine (Invitrogen), 1%
vitamins for MEM (Invitrogen), 10 µL/mL
of streptomycin sulfate (1% w/v; Sigma,
Antwerp, Belgium) and 20 µL/mL of
vancomycin (0.5% w/v; Eli Lilly, Brus-
sels, Belgium). HD11 cells were cultured
in Dulbecco’s modified Eagle’s minimal
essential medium (DMEM) supplemented
with 5% heat-inactivated chicken serum,
1% sodium pyruvate, 1% L-glutamine
and 0.5% gentamycin (all products from
Invitrogen). Cultures were incubated at
5% CO2 and 37 ◦C.
2.2. Transferrins
Ovotransferrin (ovoTF), human lacto-
ferrin (hLF) and bovine lactoferrin (bLF)
purified from chicken egg white, hu-
man milk and bovine colostrum respec-
tively, were purchased from Sigma and
iron saturated essentially as previously de-
scribed [25]. Briefly, the proteins were
dissolved in 10 mM sodium bicarbon-
ate and subsequently supplemented with
sodium citrate and Fe (III) chloride (final
concentration 5 mM) (all products from
Acros Organics, Geel, Belgium). For each
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protein solution, pH was adjusted to 8
with dissolved sodium bicarbonate. After
stirring the solutions for 12 h at 4 ◦C,
dialysis was performed against 10 mM
sodium bicarbonate for 48 h at 4 ◦C.
Subsequently, proteins were concentrated
using Centricon Plus-70 Centrifugal Fil-
ter Units (Millipore, Brussels, Belgium)
as described by the manufacturer. Pro-
tein concentrations were determined spec-
trophotometrically (260 nm) as well as iron
saturation (468 nm, 1% solution). Concen-
trated protein solutions were stored at 4 ◦C
for no more than 24 h.
2.3. Transferrin cytotoxicity assays
To check the putative cytotoxic ef-
fects of transferrins, HD11 cells were
seeded in 96-well plates (Greiner Bio-
One, Wemmel, Belgium) at a concentra-
tion of 300 000 cells/mL and the follow-
ing day were exposed to concentrations
of 0.5, 1, 2.5, 5 and 10 mg/mL of trans-
ferrins in culture medium. Incubations for
24, 36 and 48 h were performed in du-
plicate. At these time points, cytotoxic-
ity in a dose-dependent manner was as-
sessed by both viable cell counts (Nikon
Eclipse TS100, 100×) after nigrosin stain-
ing and by the 3-(4,5-dimethylthiazol-2-
yl-2,5-diphenyltetrazolium bromide) MTT
assay, actually measuring mitochondrial
activity [22]. The tetrazolium salt MTT is
reduced by viable cells to a colored water-
insoluble formazan salt. After it is solu-
bilized, formazan can be quantified spec-
trophotometrically at 585 nm. The MTT
assay was performed as follows. Ten µL
MTT (5 mg/mL, Sigma) in Hanks bal-
anced salt solution (Invitrogen) was added
to each well and after 3.5 h of incubation
at 37 ◦C, the MTT solution was replaced
by 200 µL DMSO in ethanol (1/1 v/v).
The plates were agitated for 15 min on
a platform shaker (450 RPM) to dissolve
the formazan crystals and subsequently
analyzed spectrophotometrically at both
585 nm (OD1) and 620 nm (OD2). The
latter wavelength was used to correct for
cell debris and well imperfections. Final
optical densities obtained from formazan
formation were presented as OD1 minus
OD2.
2.4. Eﬀect on infectivity of Cp. psittaci
for BGM cells
Incubation of Cp. psittaci in the pres-
ence of transferrins prior to inoculation
allowed us to examine the direct anti-
chlamydial eﬀect on extracellular bacte-
ria and to determine the maximal non-
bactericidal concentration of transferrins
which was going to be used in subse-
quent adhesion and invasion assays. Bac-
teria (108 TCID50/mL) were incubated at
37 ◦C for 1 h in BGM culture medium
supplemented with transferrin concentra-
tions of 0.005, 0.05, 0.5 and 5.0 mg/mL.
Subsequently, bacteria were washed twice
(45 000× g, 45 min, 4 ◦C) in PBS and in-
oculated in BGM cells which are highly
sensitive artificial host cells routinely used
for Cp. psittaci diagnosis [35]. At 36 h
post inoculation (p.i.), bacterial replication
was quantified by an immunofluorescence
assay.
2.5. Chlamydial adhesion and invasion
assay
Protein stock solutions were diluted in
HD11 culture medium supplemented with
5.5 mg/mL glucose (Sigma) to the max-
imal non-cytotoxic and non-bactericidal
concentrations of 0.05 mg/mL ovoTF and
0.5 mg/mL hLF and bLF. Additionally,
0.005 mg/mL ovoTF was tested. All media
were filter sterilized (0.22 µm, Millipore).
HD11 cells, seeded at 300 000 cells/mL,
were grown on sterile glass coverslips
(13 mm) at the bottom of Chlamydia Trac
bottles (Bibby Sterilin Ltd., Stone, UK)
for 24 h at 37 ◦C and 5% CO2. The cells
were inoculated with 20 µL of Cp. psittaci
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strain 92/1293 (108 TCID50/mL) follow-
ing standard procedures [35], only with-
out using cycloheximide, since it could
inhibit actin polymerization during the en-
try phase of the bacteria, and inoculation
at 4 ◦C for 15 min (1000× g) instead
of 37 ◦C to synchronize irreversible at-
tachment and entry [29]. Monolayers were
washed to remove unattached bacteria and
culture medium with the appropriate con-
centrations of transferrins was added. Cells
inoculated with PBS served as uninfected,
untreated controls. All transferrin concen-
trations were tested in duplicate and the
experiments were performed twice. Inocu-
lated cells were further incubated at 37 ◦C
and 5% CO2 till the bacteria and the actin
skeleton were stained at 15 min (optimal
timepoint for visualization of actin poly-
merization as observed in infected non-
treated controls) and at 1, 6 and 48 h p.i.
by an immunofluorescence assay.
2.6. Eﬀect on intracellular replicating
Cp. psittaci
Non-cytotoxic transferrin concentra-
tions of 0.005 to 5.0 mg/mL ovoTF and
0.005 to 1 mg/mL for both hLF and bLF
were added to the HD11 culture medium
at 3 h p.i., when all bacteria had entered
the cells and binary fission was about to
start. The outcome of the infection at 48 h
p.i. was analyzed by immunofluorescence
staining using a scoring system from 0 to 5
as previously described [34].
2.7. Immunofluorescence assays
The bactericidal eﬀect of diﬀerent trans-
ferrins as well as their eﬀect on attachment,
invasion and intracellular bacterial replica-
tion was examined by immunofluorescence
staining. All stainings were performed as
follows. The cells were washed twice with
PBS and then fixed with 4% paraformalde-
hyde (Merck, VWR, Leuven, Belgium)
and 120 mM sucrose (Merck) in PBS for
30 min at room temperature. After wash-
ing once more, the cells were incubated
for 10 min with 50 mM NH4Cl in PBS
at room temperature and permeabilized
in 0.05% saponin (Sigma) and 1 mg/mL
BSA (Sigma) in PBS. Cp. psittaci was de-
tected using a rabbit polyclonal antibody
against purified Cp. psittaci EB, followed
by an AlexaFluor 546 labeled goat anti-
rabbit conjugate (Molecular Probes) both
diluted 1 in 200 in PBS with 1% BSA.
At 15 min, 1 h and 6 h p.i., the actin
skeleton was visualized using AlexaFluor
488 coupled phalloidin (Molecular Probes,
Invitrogen) as described by the manu-
facturer. Coverslips were mounted using
Mowiol (Calbiochem, VWR) with 0.01%
p-phenylenediamine (PPD, Sigma) [33].
At all time points, fluorescently labeled
bacteria were quantified using an Eclipse
TE300 fluorescence microscope (Nikon)
provided with a CCD camera (Spot 3.0.1,
Diagnostic Instruments Inc.). Briefly, we
counted the number of chlamydiae at
15 min p.i. and/or chlamydial inclusions
(from 1 h p.i. to 48 h p.i.) in 81 im-
ages taken from a single slide and deter-
mined the mean. This parameter was desig-
nated ‘Mean Number of Inclusion forming
units’, further referred to as MNI. The
Tukey HSD test was used for comparison
of MNI values over time in the presence or
absence of diﬀerent transferrin concentra-
tions.
Additionally, images of chlamydial at-
tachment and invasion as well as of actin
recruitment were acquired using confocal
laser scanning microscopy (CLSM) (Radi-
ance 2000, Bio-Rad; 1000×).
3. RESULTS
3.1. Transferrin cytotoxicity assays
A preliminary experiment was car-
ried out to determine the maximal non-
cytotoxic concentration of ovoTF, hLF and
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Figure 1. Chlamydial adhesion and invasion assay. Mean Number of Inclusion forming units (MNI
± standard error of the mean) shown from 15 min to 6 h p.i. As expected, at 1 h p.i. more bacteria
have irreversibly attached to HD11 cells and subsequently internalized the host cell, when no protein
was applied. Treatment with either ovoTF or LF significantly inhibited this process.
bLF for HD11 chicken macrophages. Up to
5 mg/mL ovoTF and up to 1 mg/mL hLF
and bLF did not aﬀect any of the cytotoxic
parameters at all three time points exam-
ined. However, at 36 h p.i., the MTT assay
revealed a 25% drop in cellular metabolism
for HD11 cells treated with 0.5 mg/mL
bLF, increasing to 50% at 48 h p.i.
3.2. Eﬀect on infectivity of Cp. psittaci
for BGM cells
To determine the maximal non-
bactericidal concentration of transferrins
on Cp. psittaci, a pre-incubation experi-
ment was set up exposing Cp. psittaci
92/1293 to ten-fold dilutions of ovoTF,
hLF and bLF prior to inoculating them
on BGM cells. Pre-incubation with 0.5
to 5 mg/mL ovoTF significantly lowered
the outcome of the infection at 36 h p.i.
(data not shown). For both lactoferrins,
5 mg/mL reduced the infection outcome,
albeit not significantly as compared to the
controls. Therefore, the non-bactericidal
concentrations used in the following
adhesion and invasion assays were 0.005
and 0.05 mg/mL ovoTF and 0.5 mg/mL
human or bovine LF. Thus, the bactericidal
activity of ovoTF was higher than for
human and bovine LF.
3.3. Chlamydial adhesion and invasion
assay
The eﬀect on bacterial irreversible
adhesion and invasion was investigated
by addition of non-cytotoxic and non-
bactericidal concentrations of ovotransfer-
rin and both lactoferrins at the time of
inoculation of chicken macrophages. At
15 min p.i., all transferrin concentrations,
except 0.005 mg/mL ovoTF significantly
lowered MNI values as compared to un-
treated bacterial cultures (Fig. 1). At 1 h
p.i., all transferrins significantly (P < 0.05)
inhibited bacterial irreversible attachment
and entry and for ovoTF a dose-dependent
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inhibition could be demonstrated. At the
end of the early stage of the developmen-
tal cycle, at 6 h p.i., just before chlamydial
replication was about to start, MNI val-
ues were significantly (P < 0.05) lowered
for all transferrins except for 0.005 mg/mL
ovoTF, as compared to the untreated con-
trol. The inhibitory eﬀects of 0.05 mg/mL
ovoTF and 0.5 mg/mL of both LF were
equal.
Confocal images, taken at 15 min
(Fig. 2b) clearly demonstrated host cell
actin polymerization at the bacterial en-
try site. Inoculation in the presence of
non-cytotoxic concentrations (0.005 or
0.05 mg/mL, Fig. 2c) ovoTF significantly
inhibited actin polymerization in a dose-
dependent manner (Fig. 1). The same was
observed at 1 h p.i. (data not shown).
Interestingly, addition of bactericidal con-
centrations of transferrins resulted in the
absence of actin polymerization at the bac-
terial entry site, although the cells were
definitely still able to polymerize actin
(Fig. 2d).
Focusing on 48 h p.i., both ovoTF con-
centrations used and 0.5 mg/mL LF sig-
nificantly diminished the outcome of the
infection (P < 0.05) in HD11 cells when
compared to the control (Tab. I).
Overall, ovoTF was more eﬀective than
human and bovine LF in inhibiting HD11
infection since both attachment and in-
vasion were inhibited at a 10-fold lower
concentration.
3.4. Eﬀect on intracellular replicating
Cp. psittaci
The addition of non-cytotoxic concen-
trations of transferrins at 3 h p.i. apparently
had no eﬀect on subsequent intracellu-
lar chlamydial replication, since scores for
all treatments ranged from 4 to 5 (data
not shown), as well as for the control
(score 5).
4. DISCUSSION
Bactericidal eﬀects have previously
been described for both ovotransfer-
rin [17, 31] and lactoferrin (reviewed
in [32]), but their eﬀect on chlamydial bac-
teria has not yet been investigated. The
bactericidal eﬀect of ovoTF and human
and bovine LF on the avian pathogen
Cp. psittaci was evaluated by incubating
Cp. psittaci with diﬀerent concentrations
of these natural anti-microbial proteins
prior to infecting BGM cells. Therefore,
all proteins were iron-saturated to avoid
the occurrence of an anti-chlamydial ef-
fect by iron-sequestration. All transferrins
exhibited anti-chlamydial activity directly
towards extracellular organisms, resulting
in a lower infection rate of BGM cells as
compared to the infection rate established
by untreated control bacteria. However, the
bactericidal activity of ovoTF was higher
than for human and bovine LF. Concen-
trations of 0.5 mg/mL bLF and hLF were
too low to significantly lower the infec-
tion rate of BGM cells, while the same
amount of ovoTF could do so. There is
no obvious explanation for the diﬀerences
in anti-chlamydial activity. Maybe ovoTF,
exclusively found in birds, is simply more
adapted to destroy avian pathogens.
Chlamydiaceae are believed to medi-
ate their attachment through ligands such
as MOMP, hsp70 or OmcB (reviewed
in [16]). Considerable evidence suggests
that electrostatic interactions are involved
in an initial, reversible interaction with
the eukaryotic host cell for many, but not
all strains and species of chlamydiae [26,
28, 30]. Initial reversible attachment to
heparan sulfate-like glycosaminoglycans is
followed by irreversible binding to an un-
known secondary receptor and this leads to
the recruitment of actin to the attachment
site, formation of an actin-rich, pedestal-
like structure, and finally internalization of
the bacteria [10]. Indeed, confocal images
taken at 15 min p.i. of HD11 cells in
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Figure 2. Confocal images of infected HD11 chicken macrophages. Chlamydophila psittaci
92/1293 was allowed to attach to HD11 cells by centrifugation at 4 ◦C and whereafter the tempera-
ture was shifted to 37 ◦C for 15 min to allow chlamydial induction of host cell actin polymerization
in the presence of lactoferrin or ovotransferrin. Representative confocal images are shown: (a) un-
infected control, (b) infected, but untreated control, (c) infection in the presence of 0.05 mg/mL
ovotransferrin, (d) infection in the presence of 5 mg/mL ovotransferrin. From left to right: actin
staining (green), Cp. psittaci staining (red), merged. Arrows indicate zones of decreased actin re-
cruitment when treated with ovotransferrin. (Please consult www.vetres.org for a color version of
this figure.)
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Table I. Mean Number of Inclusion forming
units (MNI, ± standard deviation) at 48 h p.i. in
the absence (control) or presence of lactoferrin
or ovotransferrin.
Treatment Mean Number of
Inclusion forming unitsa
Control 372 ± 75
0.005 mg/mL ovoTF 63a ± 27
0.05 mg/mL ovoTF 87a ± 34
0.5 mg/mL hLF 154a ± 42
0.5 mg/mL bLF 124a ± 52
a Significantly diﬀerent (P < 0.05) from value for
untreated control as calculated by the Tukey HSD
test.
the absence of transferrins clearly showed
co-localization of attached Cp. psittaci
and underlying actin recruitment, indicat-
ing that, as observed earlier for Chlamy-
dia (C.) trachomatis, C. muridarum, Cp.
caviae and Cp. pneumoniae [8–10,29], Cp.
psittaci also induces a localized host cell
actin recruitment upon irreversible attach-
ment. However, as observed for C. tra-
chomatis attachment to HeLa cells [29],
irreversible attachment of Cp. psittaci to
HD11 cells was not always accompanied
by actin recruitment. The latter can be
explained as follows: (1) although we at-
tempted to synchronize irreversible bacte-
rial attachment by centrifugation at 4 ◦C,
synchronized entry could probably not be
guaranteed completely, (2) perhaps not all
fluorescently stained bacteria were still ac-
tive and infectious, (3) maybe, as sug-
gested earlier by Subtil et al. [29], actin
recruitment is transient, rendering it im-
possible to observe the induction of actin
recruitment for all the invasive bacteria by
the presently used immunofluorescence as-
say staining dead cells and finally, (4) Cp.
psittaci also uses a microfilament indepen-
dent entry mechanism, involving clathrin
coated pits [37].
The eﬀect of non-cytotoxic and
non-bactericidal ovoTF, hLF and bLF
concentrations on Cp. psittaci irreversible
adhesion and subsequent entry in HD11
chicken macrophages was evaluated.
Based on a former electron microscopic
study on the intracellular developmen-
tal cycle of strain 92/1293, time points
chosen to calculate the MNI per image
represented the attachment phase (15 min
p.i.), the attachment and entry phase (1 h
p.i.), the end of the internalization phase
(6 h p.i.) and the outcome of the infection
(48 h p.i.). Overall, non-cytotoxic and
non-bactericidal concentrations of ovoTF
were more eﬃcient than human and bovine
LF in inhibiting Cp. psittaci attachment
and entry in a homologous cell system,
as also shown by confocal images taken
of the chlamydial entry 15 min after
inoculation. Thus, in this experimental
avian Cp. psittaci system, ovoTF was more
active than bLF or hLF. Analogous results
were obtained by Giansanti et al. [14]
evaluating the anti-viral activity of ovoTF,
hLF and bLF on inhibiting avian Marek’s
disease virus infection in chicken embryo
fibroblast cultures.
Recently, a functional Type III secretion
system (T3SS) was described in Chlamy-
diaceae, including Cp. psittaci1, and in
C. trachomatis and Cp. caviae, the translo-
cated actin-recruiting phosphoprotein Tarp
was shown to be essential for actin re-
cruitment that coincides with bacterial
endocytosis [11]. In the present study, in-
hibition of Cp. psittaci entry by transfer-
rins was accompanied by the reduction
1 Beeckman D., Geens T., Vanrompay D., Iden-
tification and characterization of a type III se-
cretion system in Chlamydophila psittaci, in:
Longbottom D., Rocchi M. (Eds.), Diagnosis,
pathogenesis and control of animal chlamydo-
sis, Proc. Fourth Annual Workshop of COST
Action 855, Animal chlamydiosis and zoonotic
implications, Edinburgh, Midlothian, Scotland,
UK, 2006, p. 47.
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or even absence of actin recruitment at
the bacterial entry site, although the cell
was still fully capable to polymerize actin
as demonstrated by the presence of cell
spreading (Fig. 2d). Since lactoferrin binds
LPS in the outer membrane of Gram-
negative bacteria, giving the membrane
a more rigid character in this way [7],
the stability of the T3SS and secretion of
Type III secretion eﬀector proteins such as
Tarp might be aﬀected in a negative way.
Moreover, Ochoa et al. [23, 24] showed
that lactoferrin inhibits the attachment of
enteropathogenic E. coli (EPEC) to host
cells as well as actin polymerization by
disruption of the EPEC T3SS translocon
proteins EspA, B and D. Similarly, treat-
ment of Shigella flexneri with lactofer-
rin diminished the infection of host cells
by releasing and subsequently degrading
the T3SS translocon proteins IpaB and
IpaC, both homologues to the chlamydial
CopB and CopD [15]. Based on the se-
quence and structural homology between
human lactoferrin and ovoTF, a destabi-
lizing eﬀect on the T3SS or even a prote-
olytic eﬀect on chlamydial Type III secre-
tion translocon components might explain
the present observations. Currently, exper-
iments addressing the eﬀect of transferrins
on recombinantly produced T3SS translo-
con proteins are in progress.
Focusing on the outcome of the infec-
tion at 48 h p.i., both ovoTF concentra-
tions used and 0.5 mg/mL LF significantly
diminished the outcome of the infection
in HD11 macrophages as could be ex-
pected since bacterial attachment and entry
was significantly reduced. Moreover, this
inhibition of bacterial proliferation was
stronger in the presence of ovoTF, thereby
indicating a species-specific eﬀect exerted
by the proteins studied.
In conclusion, we provided evidence
for an anti-chlamydial eﬀect exerted by
lactoferrin and its avian homologue ovo-
transferrin. Our results clearly showed
a bactericidal eﬀect of both ovotrans-
ferrin and lactoferrins on extracellu-
lar Cp. psittaci. However, ovotransferrin
was apparently more eﬀective in killing
Cp. psittaci. Moreover, we demonstrated
that Cp. psittaci internalization in HD11
chicken macrophage cultures is more ef-
ficiently inhibited by ovotransferrin than
lactoferrins. The inhibition may be due
to the blocking of actin recruitment to-
wards the bacterial entry site as a result
of destabilizing the bacterial T3SS or of
proteolytic degradation of Type III secre-
tion eﬀector proteins. Based on the present
findings, ovotransferrin could be used as
a natural anti-chlamydial agent. However,
further research towards the practical ap-
plication in preventing Cp. psittaci infec-
tions in birds is needed.
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